Guest
In Germany, attention is focusing on a prenatal blood test that can leave expectant mothers facing a moral dilemma. That test determines whether an unborn child has Down syndrome (also known as trisomy 21). Now the German Parliament is debating whether the fetal test should be covered by public health insurance. Although genetic testing has been around for years, the payment issue has triggered a deeper debate about society's acceptance of children with genetic defects. Associations for people with disabilities are strongly opposed. They say this sends a signal that people with Down syndrome are unwanted. Subscribe: For more news go to: Follow DW on social media: ►Facebook: ►Twitter: ►Instagram: Für Videos in deutscher Sprache besuchen Sie:
